Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

NEXT STORY
Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19
PREV STORY
CytomX Therapeutics Announces New Employment Inducement Grant
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sensei Biotherapeutics Reports First Quarter 2021 Results and Provides Business Update

author_avatar
NASDAQ Market News

Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies

author_avatar
NASDAQ Market News

Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

author_avatar
NASDAQ Market News